Patents by Inventor Ryan L Stowe

Ryan L Stowe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HDAC inhibitor compounds and methods of treatment
    Patent number: 11731934
    Abstract: The instant invention describes hydrazide-containing compounds having therapeutic activity, and methods of treating disorders such as cancer, tumors and cell proliferation related disorders, or affect cell differentiation, dedifferentiation or transdifferentiation.
    Type: Grant
    Filed: August 21, 2020
    Date of Patent: August 22, 2023
    Assignee: University of Florida Research Foundation, Inc.
    Inventors: Daiqing Liao, William R. Roush, Ryan L. Stowe
  • HDAC INHIBITOR COMPOUNDS AND METHODS OF TREATMENT
    Publication number: 20210009509
    Abstract: The instant invention describes hydrazide-containing compounds having therapeutic activity, and methods of treating disorders such as cancer, tumors and cell proliferation related disorders, or affect cell differentiation, dedifferentiation or transdifferentiation.
    Type: Application
    Filed: August 21, 2020
    Publication date: January 14, 2021
    Inventors: Daiqing LIAO, William R. ROUSH, Ryan L. STOWE
  • HDAC inhibitor compounds and methods of treatment
    Patent number: 10807944
    Abstract: The instant invention describes hydrazide-containing compounds having therapeutic activity, and methods of treating disorders such as cancer, tumors and cell proliferation related disorders, or affect cell differentiation, dedifferentiation or transdifferentiation.
    Type: Grant
    Filed: March 30, 2015
    Date of Patent: October 20, 2020
    Assignees: University of Florida Research Foundation, Inc., The Scripps Research Institute
    Inventors: Daiqing Liao, William R. Roush, Ryan L. Stowe
  • HDAC INHIBITOR COMPOUNDS AND METHODS OF TREATMENT
    Publication number: 20170174619
    Abstract: The instant invention describes hydrazide-containing compounds having therapeutic activity, and methods of treating disorders such as cancer, tumors and cell proliferation related disorders, or affect cell differentiation, dedifferentiation or transdifferentiation.
    Type: Application
    Filed: March 30, 2015
    Publication date: June 22, 2017
    Inventors: Daiqing Liao, William R. Roush, Ryan L Stowe